{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:46:29Z","timestamp":1792856789261,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejphar.2019.172499","type":"journal-article","created":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T09:24:42Z","timestamp":1561281882000},"page":"172499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Dopamine D1 receptor agonists inhibit lung metastasis of breast cancer reducing cancer stemness"],"prefix":"10.1016","volume":"859","author":[{"given":"Liang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172499_bib1","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr2333","article-title":"Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients","volume":"11","author":"Aktas","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172499_bib2","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2019.172499_bib3","author":"ALDEFLUORTM Kit |"},{"key":"10.1016\/j.ejphar.2019.172499_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1590\/S0102-86502013000200010","article-title":"Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression","volume":"28","author":"Antonio","year":"2013","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.ejphar.2019.172499_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","article-title":"Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay","volume":"31","author":"Baccelli","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2019.172499_bib6","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-06-0169","article-title":"Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype","volume":"12","author":"Balic","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172499_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15537\/smj.2015.3.9622","article-title":"CD44 as a potential diagnostic tumor marker","volume":"36","author":"Basakran","year":"2015","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.ejphar.2019.172499_bib58","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2885.2011.01319.x","article-title":"Preliminary pharmacokinetics and cardiovascular effects of fenoldopam continuous rate infusion in six healthy dogs","volume":"35","author":"Bloom","year":"2012","journal-title":"J. Vet. Pharmacol. Ther"},{"key":"10.1016\/j.ejphar.2019.172499_bib8","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1038\/onc.2015.369","article-title":"Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer","volume":"35","author":"Borcherding","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2019.172499_bib9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrc1694","article-title":"Migrating cancer stem cells \u2014 an integrated concept of malignant tumour progression","volume":"5","author":"Brabletz","year":"2005","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejphar.2019.172499_bib59","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2165\/00003495-199754040-00008","article-title":"Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies","volume":"54","author":"Brogden","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2019.172499_bib10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1101\/gad.277681.116","article-title":"Distinctive properties of metastasis-initiating cells","volume":"30","author":"Celi\u00e0-Terrassa","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2019.172499_bib11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","article-title":"Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature","volume":"69","author":"Charafe-Jauffret","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172499_bib12","doi-asserted-by":"crossref","unstructured":"Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X.Q., He, J., n.d. Cancer statistics in China, 2015. CA. Cancer J. Clin. 66, 115\u2013132. https:\/\/doi.org\/10.3322\/caac.21338.","DOI":"10.3322\/caac.21338"},{"key":"10.1016\/j.ejphar.2019.172499_bib13","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/sj.mt.6300310","article-title":"Rejection of metastatic 4T1 breast cancer by attenuation of treg cells in combination with immune stimulation","volume":"15","author":"Chen","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2019.172499_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172499_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejphar.2019.172499_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejphar.2019.172499_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0024-3205(97)00404-9","article-title":"Dual actions of (\u2212)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum","volume":"61","author":"Dong","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2019.172499_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","article-title":"Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors","volume":"82","author":"duPre\u2019","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejphar.2019.172499_bib19","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0024-3205(85)90049-9","article-title":"Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam1 (SKF 82526) to D-1 receptors in rat striatum","volume":"36","author":"Flaim","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2019.172499_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jtbi.2014.02.025","article-title":"Evolution of acquired resistance to anti-cancer therapy","volume":"0","author":"Foo","year":"2014","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.ejphar.2019.172499_bib21","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2019.172499_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejphar.2019.172499_bib23","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/bcr2106","article-title":"Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells","volume":"10","author":"Grimshaw","year":"2008","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172499_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-384921-2.00006-9","article-title":"Modulation of immune cell function by \u03b11-adrenergic receptor activation","volume":"67","author":"Grisanti","year":"2011","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.ejphar.2019.172499_bib25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11095-016-2071-5","article-title":"Pharmacokinetic-pharmacodynamic modeling of the anti-tumor effect of sunitinib combined with dopamine in the human non-small cell lung cancer xenograft","volume":"34","author":"Hao","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2019.172499_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2125.1985.tb02608.x","article-title":"The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man","volume":"19","author":"Harvey","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172499_bib60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1399-6576.1981.tb01661.x","article-title":"Dopamine infusion in man. Plasma catecholamine levels and pharmacokinetics","volume":"25","author":"J\u00e4rnberg","year":"1981","journal-title":"Acta Anaesthesiol. Scand"},{"key":"10.1016\/j.ejphar.2019.172499_bib27","doi-asserted-by":"crossref","DOI":"10.3791\/51046-v","article-title":"In vitro cell migration and invasion assays","author":"Justus","year":"2014","journal-title":"J. Vis. Exp. JoVE"},{"key":"10.1016\/j.ejphar.2019.172499_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.110.173948","article-title":"Functional selectivity and biased receptor signaling","volume":"336","author":"Kenakin","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.172499_bib29","doi-asserted-by":"crossref","first-page":"21248","DOI":"10.1073\/pnas.1015855107","article-title":"Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes","volume":"107","author":"Kowanetz","year":"2010","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejphar.2019.172499_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejphar.2019.172499_bib31","doi-asserted-by":"crossref","first-page":"18115","DOI":"10.1073\/pnas.1006732107","article-title":"Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models","volume":"107","author":"Liu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2019.172499_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13046-018-0685-7","article-title":"The viable circulating tumor cells with cancer stem cells feature, where is the way out?","volume":"37","author":"Luo","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172499_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature10694","article-title":"Interactions between cancer stem cells and their niche govern metastatic colonization","volume":"481","author":"Malanchi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172499_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/acsbiomaterials.7b00041","article-title":"In vitro modeling of mechanics in cancer metastasis","volume":"4","author":"Malandrino","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ejphar.2019.172499_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic latency and immune evasion through autocrine inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172499_bib36","doi-asserted-by":"crossref","first-page":"45686","DOI":"10.1038\/srep45686","article-title":"Inhibitory effects of dopamine receptor D1 agonist on mammary tumor and bone metastasis","volume":"7","author":"Minami","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2019.172499_bib37","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJMra010253","article-title":"Fenoldopam \u2014 a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension","volume":"345","author":"Murphy","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172499_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00213-008-1172-1","article-title":"The antipsychotic potential of l-stepholidine\u2014a naturally occurring dopamine receptor D1 agonist and D2 antagonist","volume":"199","author":"Natesan","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.ejphar.2019.172499_bib39","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1158\/0008-5472.CAN-12-2037","article-title":"miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4","volume":"73","author":"Okuda","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172499_bib61","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0895-7061(99)00059-X","article-title":"Fenoldopam: a new parenteral antihypertensive Consensus roundtable on the management of perioperative hypertension and hypertensive crises","volume":"12","author":"Oparil","year":"1999","journal-title":"Am. J. Hypertens"},{"key":"10.1016\/j.ejphar.2019.172499_bib40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejphar.2019.172499_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2009.12.007","article-title":"Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content","volume":"140","author":"Pece","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172499_bib42","article-title":"Investigating metastasis using in vitro platforms","author":"Pouliot","year":"2013","journal-title":"Landes Biosci."},{"key":"10.1016\/j.ejphar.2019.172499_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pbb.2009.06.018","article-title":"D1\/D2 receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice","volume":"94","author":"Qiu","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2019.172499_bib44","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-13-3456","article-title":"The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation","volume":"74","author":"Raha","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172499_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10585-015-9755-9","article-title":"Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors","volume":"33","author":"Rodriguez-Torres","year":"2016","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ejphar.2019.172499_bib46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/jm00155a024","article-title":"Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro- 1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines","volume":"29","author":"Ross","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172499_bib47","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","article-title":"Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells","volume":"149","author":"Sachlos","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172499_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pharmthera.2013.01.014","article-title":"Cancer stem cells and their role in metastasis","volume":"138","author":"Shiozawa","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2019.172499_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI93707","article-title":"Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis","volume":"128","author":"Sun","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172499_bib62","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1476-5381.2009.00393.x","article-title":"Oral bioavailability and brain penetration of (\u2212)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D1 and antagonist at D2 receptors, in rats","volume":"158","author":"Sun","year":"2009","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.ejphar.2019.172499_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2009.06.027","article-title":"Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer","volume":"288","author":"Theodoropoulos","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2019.172499_bib52","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2019.172499_bib53","first-page":"10","article-title":"Study on the differentiation of laryngeal carcinoma and nasopharyngeal carcinoma cell line by chitosan and retinoic acid","volume":"7","author":"Wang","year":"1997","journal-title":"J. Third Mil. Med. Univ."},{"key":"10.1016\/j.ejphar.2019.172499_bib54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bcp.2015.03.013","article-title":"Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: involvement of eradicating cancer stem-like cells","volume":"95","author":"Wang","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172499_bib55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/157015907782793649","article-title":"The neuropharmacology of (-)-Stepholidine and its potential applications","volume":"5","author":"Yang","year":"2007","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2019.172499_bib56","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","article-title":"let-7 regulates self renewal and tumorigenicity of breast cancer cells","volume":"131","author":"Yu","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172499_bib57","first-page":"721","article-title":"[Effects of l-stepholidine on the peripheral vascular dopamine DA1 and DA2 receptor subtypes]","volume":"33","author":"Zhang","year":"1998","journal-title":"Yao Xue Xue Bao"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:29:09Z","timestamp":1757975349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919304510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":61,"alternative-id":["S0014299919304510"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172499","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine D1 receptor agonists inhibit lung metastasis of breast cancer reducing cancer stemness","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172499"}}